SCHEMBL2470248

SCHEMBL2470248

Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C(O)(OP(O)(=S)OC(O)[C@@H]2O[C@H](n3ccc(=O)[nH]c3=O)C(O)C2O)C1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RNASEL Q05823 4/20 0.51
P2RY2 P41231 2/20 0.47
FHIT P49789 3/20 0.42
ADORA1 P30542 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
DPP4 P27487 1/20 0.42
MEN1 O00255 1/20 0.42
SLC28A1 O00337 1/20 0.42
MAP3K7 O43318 1/20 0.42
SLC28A2 O43868 1/20 0.42
GAPDH P04406 1/20 0.42
ADORA3 P0DMS8 1/20 0.42
MAPK1 P28482 1/20 0.42
ADORA2A P29274 1/20 0.42
ADORA2B P29275 1/20 0.42
STAT6 P42226 1/20 0.42
PI4KA P42356 1/20 0.42
KMT2A Q03164 1/20 0.42
PI4K2B Q8TCG2 1/20 0.42
DOT1L Q8TEK3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2470239 1.00 RNASEL (0.51) RNASELP2RY2FHITADORA1SMN1; SMN2
SCHEMBL2470251 1.00 RNASEL (0.51) RNASELP2RY2FHITADORA1SMN1; SMN2
SCHEMBL2470237 0.91 RNASEL (0.53) RNASELP2RY2FHITADORA1SMN1; SMN2
SCHEMBL18259721 0.87 P2RY12 (0.41) RNASELP2RY2ADORA1ADORA3ADORA2A
SCHEMBL18259722 0.87 P2RY12 (0.41) RNASELP2RY2ADORA1ADORA3ADORA2A
SCHEMBL2474507 0.82 SLC28A1 (0.45) P2RY2SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL2474494 0.82 SLC28A1 (0.45) P2RY2SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL16495068 0.82 SLC28A1 (0.45) P2RY2SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL2470818 0.80 SLC28A1 (0.43) P2RY2SLC28A1SLC28A2SLC29A1SLC28A3
SCHEMBL16495245 0.80 SLC28A1 (0.43) P2RY2SLC28A1SLC28A2SLC29A1SLC28A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2370451-A2 METHOD FOR THE SYNTHESIS OF PHOSPHORUS ATOM MODIFIED NUCLEIC ACIDS Chiralgen, Ltd. (JP) 2011-10-05 EP disclosed
WO-2010064146-A2 METHOD FOR THE SYNTHESIS OF PHOSPHORUS ATOM MODIFIED NUCLEIC ACIDS CHIRALGEN, LTD. (JP) 2010-06-10 WO disclosed